These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8945532)

  • 21.
    Sharma S; Bhatnagar R; Gaur D
    Front Immunol; 2020; 11():462. PubMed ID: 32296419
    [No Abstract]   [Full Text] [Related]  

  • 22. CD14 impairs host defense against gram-negative sepsis caused by Burkholderia pseudomallei in mice.
    Wiersinga WJ; de Vos AF; Wieland CW; Leendertse M; Roelofs JJ; van der Poll T
    J Infect Dis; 2008 Nov; 198(9):1388-97. PubMed ID: 18855560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living dangerously: Burkholderia pseudomallei modulates phagocyte cell death to survive.
    Krakauer T
    Med Hypotheses; 2018 Dec; 121():64-69. PubMed ID: 30396496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    Weis JJ; Law SK; Levine RP; Cleary PP
    J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.
    Reed WP
    Immunology; 1975 Jun; 28(6):1051-9. PubMed ID: 1132888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison by electron microscopy of intracellular events and survival of Burkholderia pseudomallei in monocytes from normal subjects and patients with melioidosis.
    Puthucheary SD; Nathan SA
    Singapore Med J; 2006 Aug; 47(8):697-703. PubMed ID: 16865211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opsonophagocytosis of Chlamydia pneumoniae by Human Monocytes and Neutrophils.
    Lausen M; Pedersen MS; Rahman NSK; Holm-Nielsen LT; Farah FYM; Christiansen G; Birkelund S
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32284372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric quantitation of oxidative product formation by polymorphonuclear leukocytes during phagocytosis.
    Szejda P; Parce JW; Seeds MS; Bass DA
    J Immunol; 1984 Dec; 133(6):3303-7. PubMed ID: 6491287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Pathogenic Patterns of
    Chen YL; Hsu DW; Hsueh PT; Chen JA; Shih PJ; Lee S; Lin HH; Chen YS
    Am J Trop Med Hyg; 2019 Oct; 101(4):736-745. PubMed ID: 31392941
    [No Abstract]   [Full Text] [Related]  

  • 33. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence.
    DeShazer D; Brett PJ; Woods DE
    Mol Microbiol; 1998 Dec; 30(5):1081-100. PubMed ID: 9988483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
    Van Dijk WC; Verbrugh HA; van der Tol ME; Peters R; Verhoef J
    Infect Immun; 1979 Aug; 25(2):603-9. PubMed ID: 385502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of alternative complement pathway opsonization by group A streptococcal M protein.
    Peterson PK; Schmeling D; Cleary PP; Wilkinson BJ; Kim Y; Quie PG
    J Infect Dis; 1979 May; 139(5):575-85. PubMed ID: 374652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum complement factor I decreases Staphylococcus aureus phagocytosis.
    Cunnion KM; Buescher ES; Hair PS
    J Lab Clin Med; 2005 Nov; 146(5):279-86. PubMed ID: 16242527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Activities of O-Polysaccharide and Hemolysin Coregulated Protein 1 Specific Antibodies Isolated from Melioidosis Patients.
    Pumpuang A; Paksanont S; Burtnick MN; Brett PJ; Chantratita N
    Infect Immun; 2022 Nov; 90(11):e0021422. PubMed ID: 36226942
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Muangsombut V; Withatanung P; Srinon V; Chantratita N; Stevens MP; Blackwell JM; Korbsrisate S
    Front Cell Infect Microbiol; 2017; 7():350. PubMed ID: 28848712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
    Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.